These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28577949)

  • 101. Association between
    Lin CH; Yang PJ; Lin SH; Yeh KT; Tsao TC; Chen YE; Lin SH; Yang SF
    Diagnostics (Basel); 2020 Sep; 10(9):. PubMed ID: 32937815
    [No Abstract]   [Full Text] [Related]  

  • 102. Impact of Cytological Sampling on EGFR Mutation Testing in Stage III-IV Lung Adenocarcinoma.
    Davies RS; Smith C; Edwards G; Butler R; Parry D; Lester JF
    Lung Cancer Int; 2017; 2017():9614938. PubMed ID: 28367333
    [No Abstract]   [Full Text] [Related]  

  • 103. [Gene polymorphism and physical constitution theory: starting point of exploring syndromes of lung cancer].
    Su W; Xu ZY
    Zhong Xi Yi Jie He Xue Bao; 2010 Jan; 8(1):15-9. PubMed ID: 20082752
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Pneumonic-type lung adenocarcinoma with different ranges exhibiting different clinical, imaging, and pathological characteristics.
    Huo JW; Huang XT; Li X; Gong JW; Luo TY; Li Q
    Insights Imaging; 2021 Nov; 12(1):169. PubMed ID: 34787725
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Should the treatment of advanced lepidic adenocarcinoma be adapted to the pathological subtype?
    Paesmans M
    Eur Respir J; 2015 Nov; 46(5):1259-61. PubMed ID: 26521278
    [No Abstract]   [Full Text] [Related]  

  • 106. Phenotypic and clinical characterization of low density neutrophils in patients with advanced lung adenocarcinoma.
    Liu Y; Hu Y; Gu F; Liang J; Zeng Y; Hong X; Zhang K; Liu L
    Oncotarget; 2017 Oct; 8(53):90969-90978. PubMed ID: 29207617
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Correction to: p14
    Ozenne P; Dayde D; Brambilla E; Eymin B; Gazzeri S
    Oncogene; 2021 May; 40(20):3633-3634. PubMed ID: 33947964
    [No Abstract]   [Full Text] [Related]  

  • 108. Retraction Notice: Adenocarcinoma of the lung with scattered consolidation: Radiological–pathological correlation and prognosis.
    Eur J Radiol; 2015 Sep; 84(9):1828. PubMed ID: 26509194
    [No Abstract]   [Full Text] [Related]  

  • 109. Novel
    van der Leest C; Wagner A; Pedrosa RM; Aerts JG; Dinjens WNM; Dubbink HJ
    JCO Precis Oncol; 2018; 2():. PubMed ID: 32913987
    [No Abstract]   [Full Text] [Related]  

  • 110. Management of stage IA
    Pirker R
    J Thorac Dis; 2018 Sep; 10(Suppl 26):S3260-S3262. PubMed ID: 30370132
    [No Abstract]   [Full Text] [Related]  

  • 111. Clinical outcomes of platinum-based chemotherapy according to T790M mutation status in EGFR-positive non-small cell lung cancer patients after initial EGFR-TKI failure.
    Yoshida T; Kuroda H; Oya Y; Shimizu J; Horio Y; Sakao Y; Hida T; Yatabe Y
    Lung Cancer; 2017 Jul; 109():89-91. PubMed ID: 28577956
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Monitoring for and Characterizing Crizotinib Progression: A Chart Review of ALK-Positive Non-Small Cell Lung Cancer Patients.
    Bendaly E; Dalal AA; Culver K; Galebach P; Bocharova I; Foster R; Sasane M; Macalalad AR; Guérin A
    Adv Ther; 2017 Jul; 34(7):1673-1685. PubMed ID: 28578501
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
    Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
    Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.
    Eriguchi T; Takeda A; Sanuki N; Tsurugai Y; Aoki Y; Oku Y; Hara Y; Akiba T; Shigematsu N
    Lung Cancer; 2017 Jul; 109():62-67. PubMed ID: 28577952
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Association of MTH1 expression with the tumor malignant potential and poor prognosis in patients with resected lung cancer.
    Fujishita T; Okamoto T; Akamine T; Takamori S; Takada K; Katsura M; Toyokawa G; Shoji F; Shimokawa M; Oda Y; Nakabeppu Y; Maehara Y
    Lung Cancer; 2017 Jul; 109():52-57. PubMed ID: 28577950
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Expression and copy number gains of the RET gene in 631 early and mid stage non-small cell lung cancer cases.
    Tan L; Hu Y; Tao Y; Wang B; Xiao J; Tang Z; Lu T; Tang H
    Thorac Cancer; 2018 Apr; 9(4):445-451. PubMed ID: 29473341
    [TBL] [Abstract][Full Text] [Related]  

  • 117. The impact of preoperative elevated serum C-reactive protein on postoperative morbidity and mortality after anatomic resection for lung cancer.
    Lopez-Pastorini A; Riedel R; Koryllos A; Beckers F; Ludwig C; Stoelben E
    Lung Cancer; 2017 Jul; 109():68-73. PubMed ID: 28577953
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers.
    Goodman AM; Kato S; Bazhenova L; Patel SP; Frampton GM; Miller V; Stephens PJ; Daniels GA; Kurzrock R
    Mol Cancer Ther; 2017 Nov; 16(11):2598-2608. PubMed ID: 28835386
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
    Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
    Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.